Ameriprise’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.8M Buy
1,900,603
+1,319,386
+227% +$12.1M ﹤0.01% 1546
2026
Q2
$4.49M Buy
+581,217
New +$3.95M ﹤0.01% 2618

Other funds holding SGMT

Ameriprise's SGMT Position: Q3 2026 in Review

Ameriprise increased its Sagimet Biosciences (SGMT) stake by 227% in Q3 2026, buying an estimated $12.1M and bringing the position to 1,900,603 shares worth $18.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Ameriprise first reported a position in SGMT in Q2 2026 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • Ameriprise held 1,900,603 shares of Sagimet Biosciences worth $18.8M as of Q3 2026.
  • Ameriprise bought 1,319,386 Sagimet Biosciences shares in Q3 2026, an estimated $12.1M.
  • Sagimet Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #1546 holding.
  • Ameriprise first reported a position in Sagimet Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 129 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.